These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 372512

  • 1. Idiopathic rapidly progressive glomerulonephritis with C3 nephritic factor and hypocomplementemia.
    Davis CA, McAdams AJ, Wyatt RJ, Forristal J, McEnery PT, West CD.
    J Pediatr; 1979 Apr; 94(4):559-63. PubMed ID: 372512
    [Abstract] [Full Text] [Related]

  • 2. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E, Yagüe J, Vives J, Revert L.
    Med Clin (Barc); 1981 Jun 10; 77(1):21-6. PubMed ID: 7253758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Jun 10; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 6. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M, Ohi H, Watanabe S, Kojima H, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 May 10; 29(5):585-8. PubMed ID: 3656714
    [No Abstract] [Full Text] [Related]

  • 7. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr 10; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Mar 10; 31(3):427-34. PubMed ID: 9506679
    [Abstract] [Full Text] [Related]

  • 10. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
    Ohmori F, Ohi H, Seki M, Watanabe S, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 Apr 10; 29(4):493-8. PubMed ID: 3656707
    [No Abstract] [Full Text] [Related]

  • 11. Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis: serial complement and nephritic factor measurements and the problem of recurrence of disease.
    Curtis JJ, Wyatt RJ, Bhathena D, Lucas BA, Holland NH, Luke RG.
    Am J Med; 1979 Feb 10; 66(2):216-25. PubMed ID: 371395
    [Abstract] [Full Text] [Related]

  • 12. [Behavior of the nephritic factor and of circulating immune complexes in cryoglobulinemic glomerulonephritis].
    Pertosa G, Vox E, Pastore A, Schena FP.
    Minerva Nefrol; 1979 Feb 10; 26(3):251-5. PubMed ID: 262262
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
    Ohi H, Watanabe S, Seki M, Fujita T, Ohmori F, Hatano M.
    Nephron; 1987 Feb 10; 46(2):217-8. PubMed ID: 3600936
    [No Abstract] [Full Text] [Related]

  • 15. Mesangiocapillary glomerulonephritis and persistent hypocomplementemia.
    Cameron JS, Ogg CS, Turner DR, Weller RO, White RH, Glasgow EF, Peters DK, Martin A.
    Perspect Nephrol Hypertens; 1973 Feb 10; 1 Pt 1():541-56. PubMed ID: 4220250
    [No Abstract] [Full Text] [Related]

  • 16. Test for C3 nephritic factor activity by immunofixation electrophoresis.
    Koch FJ, Jenis EH, Valeski JE.
    Am J Clin Pathol; 1981 Jul 10; 76(1):63-7. PubMed ID: 6789671
    [Abstract] [Full Text] [Related]

  • 17. Alternative C3 pathway activiation in pneumococcal glomerulonephritis.
    Hyman LR, Jenis EH, Hill GS, Zimmerman SW, Burkholder PM.
    Am J Med; 1975 Jun 10; 58(6):810-4. PubMed ID: 1094828
    [Abstract] [Full Text] [Related]

  • 18. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
    West CD, Witte DP, McAdams AJ.
    Am J Kidney Dis; 2001 Jun 10; 37(6):1120-30. PubMed ID: 11382679
    [Abstract] [Full Text] [Related]

  • 19. Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
    Ohi H, Watanabe S, Fujita T, Seki M, Hatano M.
    J Immunol Methods; 1990 Jul 20; 131(1):71-6. PubMed ID: 2380570
    [Abstract] [Full Text] [Related]

  • 20. Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.
    West CD, Bissler JJ.
    Pediatr Nephrol; 2008 Oct 20; 23(10):1867-76. PubMed ID: 18594868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.